Fullscript

Fullscript

, a leading platform for practitioners delivering whole-person care, today announced that

，一个为提供全人照护的从业者而设的领先平台，今日宣布

L

L

Catterton

卡特顿

and

和

Altas Partners (Altas)

Altas Partners（Altas）

have agreed to acquire a majority stake in the Company from

已同意从以下方收购公司的多数股权

HGGC, LLC

HGGC有限责任公司

and

和

Snapdragon Capital Partners, LLC (Snapdragon)

Snapdragon Capital Partners, LLC（Snapdragon）

. The investment will help Fullscript further expand its platform and clinical support capabilities for practitioners and extend its reach across the North American healthcare market. Financial terms of the transaction were not disclosed.

此次投资将助力 Fullscript 进一步拓展其面向从业者的平台及临床支持能力，并扩大其在北美医疗健康市场的影响力。交易的具体财务条款未予披露。

Founded in 2011, Fullscript supports practitioners with an integrated platform providing access to data, diagnostic resources, and tools they use to deliver more personalized, preventative care. Today, more than 135,000 healthcare practitioners use Fullscript to support care for 10 million patients annually across North America, with capabilities spanning evidence-based, practitioner-directed supplement recommendations and fulfillment, laboratory management, wearable health data integration, and tools designed to improve patient adherence and outcomes..

Fullscript 成立于 2011 年，通过一个集成平台支持医疗从业者，提供数据、诊断资源以及他们用于提供更加个性化和预防性护理的工具。如今，超过 135,000 名医疗从业者使用 Fullscript，每年在北美地区为 1,000 万名患者提供护理支持，其功能涵盖基于证据、由从业者指导的补充剂推荐与履约、实验室管理、可穿戴健康数据整合，以及旨在提高患者依从性和治疗效果的工具。

“Practitioners are at the core of our business. We have built Fullscript around a simple belief: they should have the tools and information needed to see the whole patient and deliver better care. That belief will continue to guide how we grow. Altas and

“从业者是我们业务的核心。我们围绕一个简单的信念构建了 Fullscript：他们应该拥有所需的工具和信息，以全面了解患者并提供更优质的护理。这一信念将继续指导我们的发展。Altas 和

L

L

Catterton share our conviction in where healthcare is headed, and their investment and experience will help us accelerate that vision,” said Kyle Braatz, Co-Founder and CEO at Fullscript. “We are grateful to HGGC and Snapdragon for the invaluable support over the last five years and are excited for the next chapter ahead.”.

“Catterton 与我们对医疗保健行业未来发展方向抱有相同的信念，他们的投资和经验将帮助我们加速实现这一愿景，”Fullscript 联合创始人兼首席执行官 Kyle Braatz 表示。“我们感谢 HGGC 和 Snapdragon 在过去五年中提供的宝贵支持，并对即将到来的新篇章充满期待。”

“The convergence of conventional and functional medicine is happening at a rapid pace. Millions of Americans are seeking trusted sources of education and treatment solutions to manage chronic conditions and prevent disease in order to live their healthiest life. Practitioners require a platform that can provide trusted whole-health protocols and products that are integrated into their daily practice management and assures safety and efficacy.

传统医学与功能医学的融合正迅速推进。数百万美国人正在寻求可靠的教育来源和治疗方案，以管理慢性疾病、预防疾病，从而活出最健康的人生。从业者需要一个平台，能够提供可信的整体健康方案和产品，并将其整合到日常执业管理中，同时确保安全性与有效性。

Fullscript does just that. We are looking forward to helping the Fullscript team continue to build the most trusted and independent brand in all of whole-health care,” said Marc Magliacano, Managing Partner at .

“Fullscript 正是如此。我们期待帮助 Fullscript 团队继续打造整个大健康领域中最具公信力和独立性的品牌，”Managing Partner Marc Magliacano 表示。

L

L

Catterton.

卡特顿。

“Fullscript has become integral to healthcare practitioners by building a comprehensive platform around their evolving needs. Working alongside Kyle and the team, we will leverage our relationships and operating resources to build on Fullscript’s strong momentum, deepen practitioner support, and help more patients take a proactive approach to extending their healthspan,” Rajan Shah, Partner at .

“Fullscript 通过围绕医疗保健从业者不断变化的需求构建一个综合平台，已成为他们不可或缺的一部分。我们将与 Kyle 及其团队携手合作，利用我们的关系网络和运营资源，在 Fullscript 强劲的发展势头上再接再厉，深化对从业者的支持，并帮助更多患者采取主动措施以延长其健康寿命。”Rajan Shah 表示，他是 . 的合伙人。

L

L

Catterton, added.

卡特顿补充道。

“Fullscript has established itself as a clear leader in whole-person care, with an exceptional management team and a differentiated model that position the company for significant continued growth,” said Paul Emery, Partner at Altas. “We have spent considerable time studying this market and have been particularly impressed by the strength of Fullscript’s platform, the trust it has earned from practitioners, and the critical role it plays in helping them care for their patients.”.

“Fullscript 已确立其在整体健康护理领域的明确领先地位，凭借卓越的管理团队和差异化模式，为公司持续显著增长奠定了坚实基础。”Altas 的合伙人 Paul Emery 表示。“我们花了大量时间研究这一市场，对 Fullscript 平台的实力、其从从业者那里赢得的信任，以及在帮助从业者照顾患者方面所发挥的关键作用印象深刻。”

Akshay Kumar, Partner at Altas, added, “We make a select number of investments each year and hold ourselves to a high bar. Fullscript is exactly the kind of exceptional company we look to partner with: a category leader with a mission-driven team and compelling growth potential. We’re excited to bring our experience supporting leading healthcare businesses to help Fullscript build on its momentum in the years ahead.”.

Altas 合伙人 Akshay Kumar 补充道：“我们每年只进行少量精选投资，并坚持高标准。Fullscript 正是我们寻求合作的卓越企业典范：它是一个品类领导者，拥有以使命为驱动的团队和令人瞩目的增长潜力。我们很高兴能将支持领先医疗保健企业的经验带到 Fullscript，帮助其在未来几年中延续发展势头。”

“Over the course of our partnership, we have supported the Company’s evolution into a leading platform for practitioners delivering whole person care, including through investments in its clinical support capabilities, technology and growth initiatives,” said HGGC. “This transaction reflects the exceptional work of the Fullscript team and the meaningful value created through our partnership.

HGGC表示：“在我们合作期间，我们支持该公司发展成为面向提供全人照护的从业者的领先平台，包括通过对其临床支持能力、技术和增长计划的投资。此次交易反映了Fullscript团队的卓越工作以及我们通过合作创造的重大价值。”

We are proud of the Company’s progress and confident that Altas and .

我们对公司的进展感到自豪，并坚信 Altas 和。

L

L

Catterton are well positioned to support Fullscript as it continues to advance its mission and pursue its next phase of growth.”

“Catterton 处于有利地位，能够支持 Fullscript 在持续推进其使命并寻求下一阶段增长的过程中取得成功。”

Fullscript enters this next phase with significant momentum across its platform. Most recently, University Hospitals became the latest major health system to integrate Fullscript into its Epic workflow, enabling providers to recommend clinician-grade supplements directly within the EHR. In April 2026, the Company launched Fullscript Journeys, which enables providers to deliver more personalized, consumer-grade health experiences while keeping clinical guidance at the center of care.

Fullscript 在其平台强劲势头的推动下进入这一新阶段。最近，大学医院（University Hospitals）成为最新一家将 Fullscript 集成到其 Epic 工作流中的大型医疗系统，使医疗服务提供者能够在电子健康记录（EHR）系统内直接推荐临床级补充剂。2026 年 4 月，公司推出了 Fullscript Journeys，使医疗服务提供者能够在以临床指导为核心的前提下，提供更加个性化、消费级的健康体验。

In January 2026, Fullscript partnered with Oura to bring wearable biometric data directly into clinical workflows, giving providers a more complete view of their patients by bringing together wearable data, lab results, and treatment history in one place. The Company’s 2024 acquisition of Rupa Health added advanced laboratory ordering and management tools, further expanding the breadth of the Fullscript platform..

2026年1月，Fullscript与Oura合作，将可穿戴设备的生物识别数据直接整合到临床工作流中，通过将可穿戴设备数据、实验室检测结果和治疗历史记录集中于一处，为医疗服务提供者提供更全面的患者视图。该公司于2024年收购Rupa Health，增加了先进的实验室检测订购和管理工具，进一步拓展了Fullscript平台的广度。

Centerview Partners served as financial advisor to Fullscript. Evercore, Morgan Stanley & Co. LLC, and RBC Capital Markets served as financial advisors, and McDermott Will & Emery and Kirkland & Ellis served as legal counsel to both Altas and

Centerview Partners 担任 Fullscript 的财务顾问。Evercore、Morgan Stanley & Co. LLC 和 RBC Capital Markets 担任财务顾问，McDermott Will & Emery 和 Kirkland & Ellis 担任 Altas 及

L

L

Catterton. Jefferies LLC and William Blair served as financial advisors to HGGC and Snapdragon. The transaction is expected to close in the fourth quarter, subject to regulatory approvals and customary closing conditions.

Catterton、Jefferies LLC 和 William Blair 担任 HGGC 和 Snapdragon 的财务顾问。该交易预计将在第四季度完成，前提是获得监管批准并满足惯例交割条件。

About Fullscript

关于 Fullscript

Founded in 2011, Fullscript is a leading platform for practitioners delivering whole person care. With a full suite of clinical support tools that make it easier for practices to deliver personalized care more efficiently and effectively – Fullscript has helped over 135,000 practitioners serving 10 million patients with seamless access to high-quality supplements, industry-leading labs, and smart adherence tools.

Fullscript 成立于2011年，是为提供全人照护的从业者打造的领先平台。凭借一整套临床支持工具，Fullscript 帮助医疗机构更高效、更有效地提供个性化照护；目前已有超过135,000名从业者通过该平台服务1,000万名患者，使其能够无缝获取高品质补充剂、行业领先的实验室检测服务以及智能依从性管理工具。

For more information, visit .

更多信息，请访问。

fullscript.com

fullscript.com

, or follow Fullscript on

，或在以下平台关注 Fullscript

LinkedIn

领英

,

，

Instagram

Instagram

, and

，和

Facebook

脸书

.

。

About Altas Partners

关于 Altas Partners

Altas Partners is a North American private equity firm focused on selectively acquiring high-quality, durable businesses with compelling growth potential. The firm’s focused approach drives conviction and fosters deep partnerships with management teams and founders, with dedicated capabilities in operations, AI enablement, and talent to accelerate value creation.

Altas Partners 是一家北美私募股权公司，专注于选择性收购具有强劲增长潜力的高质量、稳健型企业。该公司采取聚焦策略，以坚定投资信念，并与管理团队及创始人建立深厚的合作伙伴关系；同时凭借在运营、人工智能赋能和人才领域的专业能力，加速价值创造。

Founded in 2012, Altas operates from offices in Toronto and New York, is 100% partner-owned, and manages more than $10 billion on behalf of leading global institutional investors. For more information about Altas, please visit .

Altas成立于2012年，在多伦多和纽约设有办公室，由合伙人100%持股，并为全球领先的机构投资者管理超过100亿美元的资产。欲了解有关Altas的更多信息，请访问。

altas.com

altas.com

.

。

About

关于

L

L

Catterton

卡特顿

L

L

Catterton is the largest global consumer-focused investment firm, managing approximately $40 billion of equity capital across three multi-product platforms: private equity, credit, and real estate. The firm’s funds have the ability to invest between $5 million and $5 billion, across the capital structure, in well-positioned consumer businesses.

凯特顿是全球最大的专注于消费领域的投资公司，通过私募股权、信贷和房地产三大多产品平台，管理着约400亿美元的股权资本。该公司的基金能够在资本结构的不同层级，对定位良好的消费类企业投资500万美元至50亿美元。

Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, .

依托深厚的品类洞察、卓越的运营能力以及广泛的战略关系网络，

L

L

Catterton’s team of more than 200 investment and operating professionals across 18 offices partners with management teams to drive differentiated value creation across its portfolio. Founded in 1989, the firm has made over 300 investments in some of the world’s most iconic consumer brands. For more information about .

凯特顿团队拥有遍布18个办事处的200多名投资和运营专业人士，与管理层团队携手合作，在其投资组合中推动差异化的价值创造。该公司成立于1989年，已对全球一些最具标志性的消费品牌进行了超过300项投资。欲了解更多信息，请访问。

L

L

Catterton, please visit

卡特顿，请访问

lcatterton.com

lcatterton.com

.

。

About HGGC

关于HGGC

HGGC is a values-driven, partnership-focused private investment firm. The Firm’s ecosystem of investors, operators, and professionals is united by the shared mission to develop leading enterprises and build long-term value together. HGGC invests in technology, business services, financial services, and consumer enterprises.

HGGC 是一家价值观驱动、注重合作伙伴关系的私人投资公司。公司的投资者、运营者和专业人士生态系统因共同使命而凝聚在一起，即发展领先企业并共同构建长期价值。HGGC 投资于科技、商业服务、金融服务和消费类企业。

The Firm is based in Palo Alto, Calif. and manages over $10 billion in assets under management as of March 31, 2026. More information, including a complete list of current and former investments, is available at .

该公司总部位于加利福尼亚州帕洛阿尔托，截至2026年3月31日，其管理资产规模超过100亿美元。更多信息（包括当前和以往投资的完整清单）可在以下网站获取：

hggc.com

hggc.com

.

。

About Snapdragon

关于骁龙

Founded in 2018,

成立于2018年，

Snapdragon Capital Partners

骁龙资本合伙人

is a growth equity and buyout firm making concentrated investments. The firm has a distinguished reputation in partnering with consumer companies supporting whole person health, with relevant experience in fitness, vitamins & supplements, beauty, better-for-you foods, consumer health, and consumer education..

是一家专注于集中投资的增长股权与并购公司。该公司在与支持全人健康的消费类企业合作方面享有卓越声誉，在健身、维生素与膳食补充剂、美容、健康食品、大众健康以及消费者教育等领域拥有相关经验。

Originally announced September 10th, 2026

最初于2026年9月10日宣布

Get Fresh Healthcare & IT Stories Delivered Daily

每日获取最新的医疗与IT资讯

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万已订阅我们每日通讯的医疗保健与健康IT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不会出售或泄露您的联系信息